The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction
(1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270403 · Cited by 1,005
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
Psaty, B. M. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530080036038 · Cited by 1,003
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
Cohn, J. N., Goldstein, S. O., Greenberg, B. H., Lorell, B. H., Bourge, R. C., Jaski, B. E., Gottlieb, S. O., McGrew, F., DeMets, D. L., & White, B. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392503 · Cited by 613
Davis, B. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00037-4 · Cited by 595
Cited by
Marital quality and health: A meta-analytic review.
Robles, T. F., Slatcher, R. B., Trombello, J. M., & McGinn, M. M. (2014) · Psychological Bulletin · doi:10.1037/a0031859 · Cited by 1,575
Uneasy alliance—clinical investigators and the pharmaceutical industry
Bodenheimer, T. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422024 · Cited by 765
Arena, R., Myers, J., Williams, M. A., Gulati, M., Kligfield, P., Balady, G. J., Collins, E., & Fletcher, G. (2007) · Circulation · doi:10.1161/circulationaha.106.184461 · Cited by 727
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 631
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466
Metadata
- Authors
- Temple, R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-08-25
- Volume
- 282
- Issue
- 8
- Pages
- 790
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2055665803
- Cited by
- 337
- References
- 16
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs? https://app.cochat.ai/papers/10.1001/jama.282.8.790
- The paper
- Temple, R. (1999). Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs? JAMA. https://doi.org/10.1001/jama.282.8.790
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.